Development and evaluation of candidate subunit vaccine against botulinum neurotoxin serotype B
Botulinum neurotoxins (BoNTs) are potential biological weapons because of their high toxicity and mortality. Vaccination is an effective strategy to prevent botulism. The carboxyl-terminus of the heavy chain (Hc domain) is nontoxic and sufficient to generate protective immune responses against natur...
Main Authors: | Dan-Yang Shi, Bo-Yang Chen, Yun-Yun Mao, Guo Zhou, Jian-Sheng Lu, Yun-Zhou Yu, Xiao-Wei Zhou, Zhi-Wei Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2019-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2018.1547613 |
Similar Items
-
Development and evaluation of candidate subunit vaccine and novel antitoxin against botulinum neurotoxin serotype E
by: Dan-Yang Shi, et al.
Published: (2020-01-01) -
Functional EL-HN Fragment as a Potent Candidate Vaccine for the Prevention of Botulinum Neurotoxin Serotype E
by: Zhen Li, et al.
Published: (2022-02-01) -
Immunologic and Protective Properties of Subunit- vs. Whole Toxoid-Derived Anti-Botulinum Equine Antitoxin
by: Alon Ben David, et al.
Published: (2022-09-01) -
Emerging Opportunities for Serotypes of Botulinum Neurotoxins
by: John Tapia-Núñez, et al.
Published: (2012-11-01) -
Camelid VHH Antibodies that Neutralize Botulinum Neurotoxin Serotype E Intoxication or Protease Function
by: Jacqueline M. Tremblay, et al.
Published: (2020-09-01)